These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

409 related articles for article (PubMed ID: 19941867)

  • 1. Epidemiology and control of onchocerciasis: the threshold biting rate of savannah onchocerciasis in Africa.
    Duerr HP; Eichner M
    Int J Parasitol; 2010 May; 40(6):641-50. PubMed ID: 19941867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Control of onchocerciasis in Africa: threshold shifts, breakpoints and rules for elimination.
    Duerr HP; Raddatz G; Eichner M
    Int J Parasitol; 2011 Apr; 41(5):581-9. PubMed ID: 21255577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can ivermectin mass treatments eliminate onchocerciasis in Africa?
    Winnen M; Plaisier AP; Alley ES; Nagelkerke NJ; van Oortmarssen G; Boatin BA; Habbema JD
    Bull World Health Organ; 2002; 80(5):384-91. PubMed ID: 12077614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elimination of human onchocerciasis: history of progress and current feasibility using ivermectin (Mectizan(®)) monotherapy.
    Cupp EW; Sauerbrey M; Richards F
    Acta Trop; 2011 Sep; 120 Suppl 1():S100-8. PubMed ID: 20801094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Control of onchocerciasis.
    Boatin BA; Richards FO
    Adv Parasitol; 2006; 61():349-94. PubMed ID: 16735169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Human onchocerciasis in Africa].
    Boussinesq M
    Med Trop (Mars); 1997; 57(4):389-400. PubMed ID: 9612783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Feasibility of onchocerciasis elimination with ivermectin treatment in endemic foci in Africa: first evidence from studies in Mali and Senegal.
    Diawara L; Traoré MO; Badji A; Bissan Y; Doumbia K; Goita SF; Konaté L; Mounkoro K; Sarr MD; Seck AF; Toé L; Tourée S; Remme JH
    PLoS Negl Trop Dis; 2009 Jul; 3(7):e497. PubMed ID: 19621091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short report: impact of ivermectin community-level treatments on elimination of adult Onchocerca volvulus when individuals receive multiple treatments per year.
    Cupp EW; Cupp MS
    Am J Trop Med Hyg; 2005 Dec; 73(6):1159-61. PubMed ID: 16354830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transmission of Onchocerca volvulus and prospects for the elimination of its vector, the blackfly Simulium neavei in the Mpamba-Nkusi focus in Western Uganda.
    Lakwo TL; Ndyomugyenyi R; Onapa AW; Twebaze C
    Med Vet Entomol; 2006 Mar; 20(1):93-101. PubMed ID: 16608493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Macrofilaricides and onchocerciasis control, mathematical modelling of the prospects for elimination.
    Alley WS; van Oortmarssen GJ; Boatin BA; Nagelkerke NJ; Plaisier AP; Remme JH; Lazdins J; Borsboom GJ; Habbema JD
    BMC Public Health; 2001; 1():12. PubMed ID: 11734070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The effect of ivermectin on the transmission of Onchocerca volvulus in southern Mexico].
    Rodríguez-Pérez MA; Reyes-Villanueva F
    Salud Publica Mex; 1994; 36(3):281-90. PubMed ID: 7940009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Seasonal biting pattern of Simulium damnosum s.l and its implications on onchocerciasis treatment with ivermectin.
    Adewale B; Oyerinde JP; Mafe MA
    West Afr J Med; 2008 Oct; 27(4):224-9. PubMed ID: 19469400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High infection rates at low transmission potentials in West African onchocerciasis.
    Duerr HP; Leary CC; Eichner M
    Int J Parasitol; 2006 Nov; 36(13):1367-72. PubMed ID: 16979644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The use of ivermectin in the control of onchocerciasis].
    Chippaux JP; Boussinesq M; Prod'hon J
    Sante; 1995; 5(3):149-58. PubMed ID: 7640897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progress towards onchocerciasis elimination in the participating countries of the African Programme for Onchocerciasis Control: epidemiological evaluation results.
    Tekle AH; Zouré HG; Noma M; Boussinesq M; Coffeng LE; Stolk WA; Remme JH
    Infect Dis Poverty; 2016 Jun; 5(1):66. PubMed ID: 27349645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Molecular approaches to the control of onchocerciasis in Mexico].
    Rodríguez-Pérez MA
    Rev Latinoam Microbiol; 2005; 47(3-4):112-29. PubMed ID: 17061536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The campaign against onchocerciasis in Africa: update].
    Boussinesq M; Hougard JM
    Med Trop (Mars); 1998; 58(3):285-96. PubMed ID: 10088109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined benefits of annual mass treatment with ivermectin and cattle zooprophylaxis on the severity of human onchocerciasis in northern Cameroon.
    Seidenfaden R; Fischer A; Bonow I; Ekale D; Tanya V; Renz A
    Trop Med Int Health; 2001 Sep; 6(9):715-25. PubMed ID: 11555439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Filariasis in Africa--treatment challenges and prospects.
    Hoerauf A; Pfarr K; Mand S; Debrah AY; Specht S
    Clin Microbiol Infect; 2011 Jul; 17(7):977-85. PubMed ID: 21722251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polymerase chain reaction monitoring of transmission of Onchocerca volvulus in two endemic states in Mexico.
    Rodríguez-Pérez MA; Lilley BG; Domínguez-Vázquez A; Segura-Arenas R; Lizarazo-Ortega C; Mendoza-Herrera A; Reyes-Villanueva F; Unnasch TR
    Am J Trop Med Hyg; 2004 Jan; 70(1):38-45. PubMed ID: 14971696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.